Voyager Therapeutics

159 articles about Voyager Therapeutics

• MRI' Clearpoint Neuro Navigation Technology Highlighted In Voyager Therapeutics Interim Parkinson’s Disease Gene Therapy Study Results

  6/24/2016

• Voyager Therapeutics Announces Interim Phase 1b Surgical Results For VY-AADC01 In Advanced Parkinson’s Disease

  6/22/2016

• Voyager Therapeutics Provides First Quarter 2016 Investor Update

  5/12/2016

• Voyager Therapeutics Promotes Jeff Goater To Chief Financial Officer

  2/3/2016

• Voyager Therapeutics Announces Closing Of Initial Public Offering, Including Full Exercise Of Option To Purchase Additional Shares

  11/17/2015

• Voyager Therapeutics Reels in $70 Million in IPO

  11/11/2015

• Voyager Therapeutics Plans IPO of Up to $86.3 Million

  10/12/2015

• Voyager Therapeutics Appoints Neuroscience Expert Steven Hyman, M.D., To Board Of Directors

  9/17/2015

• Voyager Therapeutics Appoints Michael Higgins To Board Of Directors

  7/22/2015

• Voyager Therapeutics Appoints Perry A. Karsen To Board Of Directors

  7/1/2015

• Voyager Therapeutics To Present At The American Society Of Gene & Cell Therapy 18th Annual Meeting

  5/5/2015

• Voyager Therapeutics Promotes Jeff Goater To Senior Vice President, Finance And Business Development

  4/28/2015

• Voyager Therapeutics Snags $60 Million With "Crossover" Investors as Analysts Predict an IPO

  4/13/2015

• Voyager Therapeutics To Present At Cowen and Company 35th Annual Health Care Conference

  2/20/2015

• Voyager Therapeutics And MassBiologics Announce Strategic Collaboration For Viral Vector Manufacturing

  12/11/2014

• Voyager Therapeutics Release: Dinah Sah, Senior Vice President Of Neuroscience And Rob Kotin, Vice President Of Production Honored Among PharmaVOICE 100 Most Inspiring People

  8/4/2014

• Voyager Therapeutics Appoints Industry Veteran Robert G. Pietrusko, Pharm.D., To Senior Vice President Of Regulatory Affairs

  6/26/2014

• Voyager Therapeutics Expands And Strengthens Scientific And Clinical Leadership To Advance Life-Changing Gene Therapies For CNS Disorders

  3/25/2014

• Third Rock Ventures Launches Gene-Therapy Startup, Voyager Therapeutics, With $45 Million Series A In Pocket

  2/12/2014